Table 3. Reaction combinations for the screening and subtyping of HLA-A*02 alleles.
Reaction | Primer combinationa | Target allelesb | Cycling protocolc | Amplicon size (bp) |
---|---|---|---|---|
For main-screening | CP1(1 min) | |||
78C/I3 | 78C-FW, A-I3-RV | GNA2 group | 881 or 882 | |
78T/I3 | 78T-FW, A-I3-RV | GA2 group | 882 | |
77G/538A | 77G-FW, 538A-RV | A*02:236 | 688 | |
Control | hB2M-FW, hB2M-RV | (Human B2M gene) | 333 | |
For sub-screening | CP2(30 s) | |||
318A/555A | 318A-FW, 555A-RV | SA2 group | 510 | |
149C/440G | 149C-FW, 440G-RV | Partial SNA2 allelesd | 516 | |
412A/555G | 412A-FW, 555G-RV | Another partial SNA2 allelese | 178 | |
For sequencing or cloning | CP1(2 min) | |||
78C/I4 | 78C-FW, A-I4-RV | GNA2 group | 1728 or 1729 | |
78T/I4 | 78T-FW, A-I4-RV | GA2 group | 1729 | |
I1/I4 | A-I1-FW, A-I4-RV | HLA-A | 1820 | |
For ambiguity resolving | CP1(30 s) | |||
F5/78T | A-F5-FW, 78T-RV | Partial GA2 alleles | 427 |
Primer information is listed in Table 2.
Expressed as Protocol(Elongation time); the cycling protocols are detailed in the section on ‘Materials and methods'.
Alleles A*01:01:13, A*03:01:12, A*11:01:34, A*24:02:58, A*25:01:07, A*26:20 and A*68:03:02.
Alleles A*01:01:13, A*03:01:12, A*03:89, A*11:01:34 and A*30:08.